Skip to main content

Hormone Replacement Therapy

Question for Department of Health and Social Care

UIN 70328, tabled on 5 November 2021

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 November 2021 to Questions 65535 and 65536 on Hormone Replacement Therapy, for what reason HRT drugs and products have been affected by supply issues.

Answered on

15 November 2021

Supply issues that have affected the availability of hormone replacement therapy (HRT) preparations include manufacturing issues, regulatory issues, problems accessing the raw pharmaceutical ingredient as well as commercial decisions made by some companies to divest these products.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.